AstraZeneca is a company with a turbulent history but, for now, a promising future. We take a look at the company's story, from its creation as a merger of two equals, to its recent major ...

AstraZeneca (GB:AZN) has released an update. AstraZeneca’s CEO, Pascal Soriot, has made a substantial investment in the company by purchasing 20,000 ordinary shares at £102.03 each. This move ...

AstraZeneca may have exited the COVID-19 vaccine market, but it is still hoping to protect vulnerable patients with its antibody sipavibart for pre-exposure prophylaxis (PrEP). The drugmaker said ...

LONDON, Nov 27 (Reuters) - AstraZeneca's (AZN.L), opens new tab Fasenra, an injectable treatment for severe asthma, is more effective during attacks than the oral steroid that has been the ...

AstraZeneca (GB:AZN) has released an update. Don't Miss our Black Friday Offers: AstraZeneca PLC, a leading biopharmaceutical company, announced its current share capital with voting rights stands ...

AstraZeneca Pharma India Ltd., incorporated in the year 1979, is a Mid Cap company (having a market cap of Rs 16,598.25 Crore) operating in Pharmaceuticals sector. AstraZeneca Pharma India Ltd. key ...

LONDON (Reuters) - AstraZeneca's Fasenra, an injectable treatment for severe asthma, is more effective during attacks than the oral steroid that has been the standard of care for 50 years ...

AstraZeneca on Wednesday appointed Iskra Reic the executive vice president for its international operations as China’s investigation into Leon Wang is underway. Wang, previously International head, is ...

AstraZeneca Plc and partner Merck & Co. filed lawsuits adding a patent issued this week to battles over copies of the blockbuster cancer drug Lynparza proposed by four generic-drug makers.

Australian mother-of-one, author, academic and child sexual abuse survivor Professor Gemma Carey has died after a battle with illness.

The failure of the trial of the drug AZD4041 by pharma giant AstraZeneca, to combat opioid use disorder (OUD), highlights the challenges in developing non-opioid medications that treat addiction ...